Comparison between HER2 extracellular domain in serum and HER2 overexpression in breast cancer tissue

被引：0
|
作者：
Zidan, J.
Mzalbat, R.
Shnaider, J.
Sharabi, A.
机构：
[1] Sieff Hosp, Safed, Israel
[2] Ziv Med Ctr, Safed, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e11066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11066
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582
  • [22] Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer
    Kong, Sun-Young
    Nam, Byung-Ho
    Lee, Keun Seok
    Kwon, Youngmee
    Lee, Eun Sook
    Seong, Moon-Woo
    Lee, Do Hoon
    Ro, Jungsil
    CLINICAL CHEMISTRY, 2006, 52 (08) : 1510 - 1515
  • [23] Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer
    Lee, Sae Byul
    Lee, Jong Won
    Yu, Jong Han
    Ko, Beom Seok
    Kim, Hee Jeong
    Son, Byung Ho
    Gong, Gyungyub
    Lee, Hee Jin
    Kim, Sung-Bae
    Jung, Kyung Hae
    Ahn, Jin-Hee
    Lee, Woochang
    Sung, Joohon
    Ahn, Sei-Hyun
    BMC CANCER, 2014, 14
  • [24] Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer
    Sae Byul Lee
    Jong Won Lee
    Jong Han Yu
    Beom Seok Ko
    Hee Jeong Kim
    Byung Ho Son
    Gyungyub Gong
    Hee Jin Lee
    Sung-Bae Kim
    Kyung Hae Jung
    Jin-Hee Ahn
    Woochang Lee
    Joohon Sung
    Sei-Hyun Ahn
    BMC Cancer, 14
  • [25] Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer
    Vivien H. C. Bramwell
    Gordon S. Doig
    Alan B. Tuck
    Sylvia M. Wilson
    Katia S. Tonkin
    Anna Tomiak
    Francisco Perera
    Theodore A. Vandenberg
    Ann F. Chambers
    Breast Cancer Research and Treatment, 2009, 114
  • [26] HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer (vol 38, pg 133, 2012)
    Tse, Chantal
    Gauchez, Anne-Sophie
    Jacot, William
    Lamy, Pierre-Jean
    CANCER TREATMENT REVIEWS, 2013, 39 (07) : 831 - 831
  • [27] Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer
    Bramwell, Vivien H. C.
    Doig, Gordon S.
    Tuck, Alan B.
    Wilson, Sylvia M.
    Tonkin, Katia S.
    Tomiak, Anna
    Perera, Francisco
    Vandenberg, Theodore A.
    Chambers, Ann F.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 503 - 511
  • [28] Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum
    Shi Qui
    Takashi Takeshita
    Aiko Sueta
    Mai Tomiguchi
    Lisa Goto-Yamaguchi
    Kaori Hidaka
    Ikuko Suzu
    Yutaka Yamamoto
    Hirotaka Iwase
    Breast Cancer, 2021, 28 : 746 - 754
  • [29] Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum
    Qui, Shi
    Takeshita, Takashi
    Sueta, Aiko
    Tomiguchi, Mai
    Goto-Yamaguchi, Lisa
    Hidaka, Kaori
    Suzu, Ikuko
    Yamamoto, Yutaka
    Iwase, Hirotaka
    BREAST CANCER, 2021, 28 (03) : 746 - 754
  • [30] Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer
    Cresti, Nicola
    Lee, Joanne
    Rourke, Emma
    Televantou, Despina
    Jamieson, David
    Verrill, Mark
    Boddy, Alan V.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : 27 - 37
12345